Gene Therapy Market size is expected to grow from US$ 6.21 Bn. in 2021 to US$ 44.51 Bn. by 2029, growing at a CAGR of 27.9% through 2022 to 2029. Spinal Muscular Atrophy (SMA) Indication segment leads the Global Gene Therapy Market by 2029.
Gene Therapy Market Overview
Maximize Market Research looks deep into the Gene Therapy Market, concentrating on each segment while considering global and regional trends. To create a balanced Gene Therapy market environment, is thoroughly addressed the drivers and main barriers. The Gene Therapy market is divided into various categories, such as products, applications, vendors, and geographies, in order to provide readers with a comprehensive view of the industry. The research also includes industry statistics that illustrate the Gene Therapy market & long-term prospects.
Click For Sample Report: https://www.maximizemarketresearch.com/request-sample/85074
Gene Therapy Market Scope
The Gene Therapy Market, report include detailed financial information about major key players, revenue sales growth, market price analysis and size and volume of the market. The report covers Gene Therapy market strategies, customer preferences, current competitor, government restrictions and future market view to the investors. Gene Therapy Market trends and segment analysis was conducted to estimate the market size. The report covers market drivers, opportunities and restraints affecting the Gene Therapy market growth.
The report includes a SWOT and PESTEL analysis of the Gene Therapy market. Also, the report evaluates the market segments based on market volume, market size, market volume, and investment potential, and incremental revenue of the Gene Therapy market. Primary and secondary research was conducted in the Gene Therapy market research. Primary research includes interviews with industry experts and Gene Therapy Market.
Segmentation
Acute Lymphoblastic Leukaemia (ALL), Inherited Retinal Disease, Large B-cell Lymphoma, ADA-SCID, Melanoma (lesions), Beta-Thalassemia Major/SCD, Head & Neck Squamous Cell Carcinoma, Peripheral Arterial Disease, Spinal Muscular Atrophy (SMA), and Others are the different indications that the market is divided into. By holding a 41% market share in 2021, the Spinal Muscular Atrophy (SMA) segment is anticipated to maintain its dominance through the year 2029. SMA, one of the most common fatal genetic childhood diseases, affects the muscles. As a gene treatment, Zolgensma (AVXS-101) has proven to be effective in curing SMA and changing the disease’s phenotype. In May 2021, the FDA approved Zolgensma, a medication developed by Novartis to address the fundamental cause of SMA.
For More Information About This Research Please Visit : https://www.maximizemarketresearch.com/market-report/global-gene-therapy-market/85074/
Key Players
• REGENXBIO, Inc.
• Bayer
• Oxford BioMedica plc
• Dimension Therapeutics, Inc.
• Bristol-Myers Squibb Company
• SANOFI
• Applied Genetic Technologies Corp
• F. Hoffmann-La Roche Ltd.
• Bluebird Bio, Inc.
• Novartis AG
• Taxus Cardium Pharmaceuticals Group, Inc. (Gene Biotherapeutics)
• UniQure N.V.
• Shire Plc;
• Cellectis S.A.
• Sangamo Therapeutics, Inc.
• Orchard Therapeutics
• Gilead Lifesciences, Inc.
• Benitec Biopharma Ltd.
• Sibiono GeneTech Co., Ltd.
• Shanghai Sunway Biotech Co., Ltd
• Gensight Biologics S.A.
• Transgene
• Calimmune, Inc
• Epeius Biotechnologies Corp
• Astellas Pharma, Inc
• American Gene Technologies
• BioMarin Pharmaceuticals, Inc.
• Human Stem Cell Institute
• Spark Therapeutics LLC
• GlaxoSmithKline
• Voyager Therapeutics
Regional Analysis
The European region, North American region, Asia-Pacific region, the Middle East and Africa region, and Latin America are the five primary world regions included in the Gene Therapy market report. The Gene Therapy market Research identifies the market’s key geographies, as well as notable segments and sub-segments. The Gene Therapy market report includes figures, geographies, revenue, and in-depth analysis of the business chain structure, opportunities, and industry news of the Gene Therapy market.
To Request Customization of the Gene Therapy Market Report, Click Here @ : https://www.maximizemarketresearch.com/request-sample/85074
Key Questions answered in the Gene Therapy Market Report are:
- What is Gene Therapy?
- What was the Gene Therapy market size in 2021?
- What is the expected Gene Therapy market size by 2029?
- What is the growth rate of the Gene Therapy Market?
- Which are the factors expected to drive the Gene Therapy market growth?
- Which segment dominated the Gene Therapy market growth?
- What is the demand pattern for the Gene Therapy market?
- Which region held the largest share in the Gene Therapy market?
- Who are the key players in the Gene Therapy market?
Key offerings:
- Market Share, Size, and Forecast by Revenue|2022-2029
- Market Dynamics- Growth drivers, Restraints, Investment Opportunities, and key trends
- Market Segmentation: A detailed analysis by Gene Therapy
- Landscape- Leading key players and other prominent key players.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include science and engineering, electronic components, industrial equipment, technology, and communication, cars, and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
